• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Drug-induced alterations in serum creatinine concentrations.

作者信息

Ducharme M P, Smythe M, Strohs G

机构信息

Department of Pharmacy Practice, Wayne State University, Detroit, MI 48202.

出版信息

Ann Pharmacother. 1993 May;27(5):622-33. doi: 10.1177/106002809302700518.

DOI:10.1177/106002809302700518
PMID:8347916
Abstract

OBJECTIVE

To provide a comprehensive review of drug-induced alterations in serum creatinine concentrations (SCrs).

DATA SOURCES

Information was obtained from a MEDLINE search, reference lists from articles identified in the search, review articles, and abstracts.

STUDY SELECTION

Emphasis was placed on clinical studies of direct relevance to clinical practitioners.

DATA EXTRACTION

Literature was assessed for its methodology, results, discussion, and conclusion.

DATA SYNTHESIS

Two analytical systems to assay SCr are commonly employed in clinical practice--the Jaffé-based and enzymatic methods. Several drugs have been reported to interfere with SCr results obtained with both analytical systems by producing assay interference. In addition, trimethoprim, cimetidine, and salicylates produce elevations in the SCr by altering the normal elimination pathways of creatinine. Phenacemide has been reported to increase creatinine elimination, but the mechanism of this effect is unknown.

CONCLUSIONS

Pharmacists should recognize the clinical significance of drug-induced interference with SCr and propose alternative methods of determining concentrations in selected patients.

摘要

相似文献

1
Drug-induced alterations in serum creatinine concentrations.
Ann Pharmacother. 1993 May;27(5):622-33. doi: 10.1177/106002809302700518.
2
Creatinine metabolism impairment by an anticonvulsant drug, phenacemide.
Ann Pharmacother. 1994 Jan;28(1):49-51. doi: 10.1177/106002809402800110.
3
A rise in plasma creatinine that is not a sign of renal failure: which drugs can be responsible?血浆肌酐升高并非肾衰竭的迹象:哪些药物可能与此有关?
J Intern Med. 1999 Sep;246(3):247-52. doi: 10.1046/j.1365-2796.1999.00515.x.
4
Creatinine reference values in ELBW infants: impact of quantification by Jaffe or enzymatic method.超低出生体重儿的肌酐参考值:Jaffe法或酶法定量的影响
J Matern Fetal Neonatal Med. 2012 Sep;25(9):1678-81. doi: 10.3109/14767058.2012.657277. Epub 2012 Feb 14.
5
Implications of serum creatinine measurements on GFR estimation and vancomycin dosing in children.血清肌酐测量对儿童肾小球滤过率估算及万古霉素给药的影响
J Clin Pharmacol. 2014 Jul;54(7):785-91. doi: 10.1002/jcph.281. Epub 2014 Mar 11.
6
Trimethoprim, creatinine and creatinine-based equations.甲氧苄啶、肌酐和基于肌酐的公式。
Nephron Clin Pract. 2011;119(3):c187-93; discussion c193-4. doi: 10.1159/000328911. Epub 2011 Aug 11.
7
Modeling the variability of creatinine measurements improves estimates of the glomerular filtration rate.对肌酐测量值的变异性进行建模可改善肾小球滤过率的估计。
Clin Chem Lab Med. 2008;46(2):215-8. doi: 10.1515/CCLM.2008.045.
8
Drug interference with renal function tests.药物对肾功能检查的干扰。
Am J Kidney Dis. 1983 Sep;3(2):118-20. doi: 10.1016/s0272-6386(83)80026-2.
9
Methods of GFR determination--creatinine clearance after cimetidine administration in clinical practice.肾小球滤过率(GFR)的测定方法——临床实践中服用西咪替丁后的肌酐清除率
Acta Med Austriaca. 2004 May;31(2):51-5.
10
Does the type of creatinine assay affect creatinine clearance determination?肌酐检测类型会影响肌酐清除率的测定吗?
Scand J Clin Lab Invest. 2014 Aug;74(5):392-8. doi: 10.3109/00365513.2014.900186. Epub 2014 Apr 29.

引用本文的文献

1
TMP-SMX induced type 4 hypersensitivity with multi-organ involvement.复方新诺明诱发了伴有多器官受累的4型超敏反应。
IDCases. 2023 Oct 26;34:e01917. doi: 10.1016/j.idcr.2023.e01917. eCollection 2023.
2
Time to Rethink the Current Paradigm for Assessing Kidney Function in Drug Development and Beyond.是时候重新思考当前药物研发及其他领域中评估肾功能的范式了。
Clin Pharmacol Ther. 2022 Nov;112(5):946-958. doi: 10.1002/cpt.2489. Epub 2021 Dec 18.
3
Kidney Injury Biomarkers in an Academic Hospital Setting: Where Are We Now?学术医院环境中的肾脏损伤生物标志物:我们目前的进展如何?
Clin Biochem Rev. 2019 May;40(2):79-97. doi: 10.33176/AACB-18-00017.
4
Wnt4 is significantly upregulated during the early phases of cisplatin-induced acute kidney injury.Wnt4 在顺铂诱导的急性肾损伤的早期阶段显著上调。
Sci Rep. 2018 Jul 12;8(1):10555. doi: 10.1038/s41598-018-28595-4.
5
Biomarkers for prediction of renal replacement therapy in acute kidney injury: a systematic review and meta-analysis.用于急性肾损伤肾替代治疗预测的生物标志物:系统评价和荟萃分析。
Intensive Care Med. 2018 Mar;44(3):323-336. doi: 10.1007/s00134-018-5126-8. Epub 2018 Mar 14.
6
[Life after Acute Kidney Injury : Long-term consequences and implications for clinical practice].[急性肾损伤后的生活:长期后果及对临床实践的影响]
Med Klin Intensivmed Notfmed. 2017 Oct;112(7):597-604. doi: 10.1007/s00063-017-0340-7. Epub 2017 Sep 5.
7
The cell cycle biomarkers: promising research, but do not oversell them.细胞周期生物标志物:研究前景广阔,但勿过度吹嘘。
Clin Kidney J. 2016 Jun;9(3):353-8. doi: 10.1093/ckj/sfw033. Epub 2016 May 24.
8
Fluctuation of the renal function after discharge from hospital and its effects on drug dosing in elderly patients--study protocol.老年患者出院后肾功能波动及其对药物剂量的影响——研究方案
BMC Nephrol. 2015 Jul 7;16:95. doi: 10.1186/s12882-015-0095-4.
9
Individualizing pharmacotherapy in patients with renal impairment: the validity of the Modification of Diet in Renal Disease formula in specific patient populations with a glomerular filtration rate below 60 ml/min. A systematic review.肾功能损害患者的个体化药物治疗:肾小球滤过率低于60 ml/min的特定患者群体中肾脏病饮食改良公式的有效性。一项系统评价。
PLoS One. 2015 Mar 5;10(3):e0116403. doi: 10.1371/journal.pone.0116403. eCollection 2015.
10
Lack of effect of DX-619, a novel des-fluoro(6)-quinolone, on glomerular filtration rate measured by serum clearance of cold iohexol.新型去氟(6)-喹诺酮DX-619对通过冷碘海醇血清清除率测定的肾小球滤过率无影响。
Antimicrob Agents Chemother. 2007 Jun;51(6):1912-7. doi: 10.1128/AAC.01223-06. Epub 2007 Mar 19.